Find Out if You Qualify for a Financial Reward by filling out the form below.
Investigation Details
Caleres reported its second quarter 2024 on September 12, 2024. The Company reported sales below analyst expectations and also lowered its yearly guidance. Following on this news, shares of Caleres fell over 19% in intraday trading on the same day. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Ticker Symbol | Company Name | Join Deadline | Join |
---|---|---|---|
WOLF | Wolfspeed, Inc. | January 17, 2025 | Join |
SUI | Sun Communities, Inc. | February 10, 2025 | Join |
SAVA | Cassava Sciences, Inc. | February 10, 2025 | Join |
APLT | Applied Therapeutics, Inc. | February 18, 2025 | Join |
BIOA | BioAge Labs, Inc. | March 10, 2025 | Join |
PCRX | Pacira BioSciences, Inc. | March 14, 2025 | Join |